Malin Corporation | MLC - Capitale Di Prestito





Capitale Di Prestito Cambiamento Data
Akebia Therapeutics USD 36.39M 11.85M 2026-03
Alaunos Therapeutics USD 4.47M 5.85M 2022-06
ALKERMES USD 1.48B 1.2B 2026-03
Avita Medical AUD 42.24M 1.25M 2024-12
Dianthus Therapeutics USD 0 0 2024-12
Eurofins Scientific SE EUR 3.7B 129.7M 2025-12
Ionis Pharmaceuticals USD 1.91B 9M 2026-03
IQVIA Holdings USD 13.99B 105M 2026-03
Lonza CHF 3.88B 323M 2025-12
Malin Corporation EUR 0 0 2024-12
Moderna USD 603M 7M 2026-03
Organon & Co USD 8.55B 75M 2026-03
Ovoca Bio EUR 0 0 2021-06
Revvity USD 2.63B 836K 2026-03
Tectonic Therapeutic USD 43K 57K 2025-12
Viatris USD 12.41B 67.1M 2026-03
Xeris Pharmaceuticals USD 221.22M 889K 2026-03